405 related articles for article (PubMed ID: 15917220)
21. NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation.
Liu A; Hoffman PW; Lu W; Bai G
J Biol Chem; 2004 Apr; 279(17):17449-58. PubMed ID: 14970236
[TBL] [Abstract][Full Text] [Related]
22. C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha.
Cappello C; Zwergal A; Kanclerski S; Haas SC; Kandemir JD; Huber R; Page S; Brand K
Cell Signal; 2009 Dec; 21(12):1918-24. PubMed ID: 19733238
[TBL] [Abstract][Full Text] [Related]
23. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
24. E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1.
Chen M; Capps C; Willerson JT; Zoldhelyi P
Circulation; 2002 Nov; 106(21):2707-13. PubMed ID: 12438297
[TBL] [Abstract][Full Text] [Related]
25. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.
Elsharkawy AM; Wright MC; Hay RT; Arthur MJ; Hughes T; Bahr MJ; Degitz K; Mann DA
Hepatology; 1999 Sep; 30(3):761-9. PubMed ID: 10462383
[TBL] [Abstract][Full Text] [Related]
26. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
27. IkappaB-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export.
Puca A; Fiume G; Palmieri C; Trimboli F; Olimpico F; Scala G; Quinto I
J Biol Chem; 2007 Dec; 282(51):37146-57. PubMed ID: 17942396
[TBL] [Abstract][Full Text] [Related]
28. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.
Mann J; Oakley F; Johnson PW; Mann DA
J Biol Chem; 2002 May; 277(19):17125-38. PubMed ID: 11886848
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.
You LR; Chen CM; Lee YH
J Virol; 1999 Feb; 73(2):1672-81. PubMed ID: 9882379
[TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65.
Fiume G; Vecchio E; De Laurentiis A; Trimboli F; Palmieri C; Pisano A; Falcone C; Pontoriero M; Rossi A; Scialdone A; Fasanella Masci F; Scala G; Quinto I
Nucleic Acids Res; 2012 Apr; 40(8):3548-62. PubMed ID: 22187158
[TBL] [Abstract][Full Text] [Related]
31. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells.
Nelson G; Paraoan L; Spiller DG; Wilde GJ; Browne MA; Djali PK; Unitt JF; Sullivan E; Floettmann E; White MR
J Cell Sci; 2002 Mar; 115(Pt 6):1137-48. PubMed ID: 11884514
[TBL] [Abstract][Full Text] [Related]
32. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain.
Wang J; Shelly L; Miele L; Boykins R; Norcross MA; Guan E
J Immunol; 2001 Jul; 167(1):289-95. PubMed ID: 11418662
[TBL] [Abstract][Full Text] [Related]
33. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.
Yan C; Wang H; Boyd DD
J Biol Chem; 2001 Jan; 276(2):1164-72. PubMed ID: 11060311
[TBL] [Abstract][Full Text] [Related]
34. POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.
Lee DK; Suh D; Edenberg HJ; Hur MW
J Biol Chem; 2002 Jul; 277(30):26761-8. PubMed ID: 12004059
[TBL] [Abstract][Full Text] [Related]
35. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2.
Kiningham KK; Xu Y; Daosukho C; Popova B; St Clair DK
Biochem J; 2001 Jan; 353(Pt 1):147-156. PubMed ID: 11115408
[TBL] [Abstract][Full Text] [Related]
39. Endotoxin-mediated regulation of nuclear factor-kappaB nuclear translocation and activation in the hippocampus of the central nervous system: modulation by intracerebroventricular treatment with thymulin and the immunomodulatory role of the IkappaB-alpha/pIkappaB-alpha pathway.
Haddad JJ
Neuroscience; 2009 Dec; 164(4):1509-20. PubMed ID: 19782726
[TBL] [Abstract][Full Text] [Related]
40. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
Juvekar A; Manna S; Ramaswami S; Chang TP; Vu HY; Ghosh CC; Celiker MY; Vancurova I
Mol Cancer Res; 2011 Feb; 9(2):183-94. PubMed ID: 21224428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
